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ABSTRACT
The physiological and behavioral circadian rhythms
of most creatures are controlled by a harmony of
functional relationships between clock genes. In
mammals, several core clock genes show rhythmic
profiles of their mRNA and protein expression.
Amongthem,Rev-erbafunctionsasatranscriptional
repressor, affecting expression patterns of other
clock genes. For the continuous and robust oscilla-
tion of the molecular clock system, the levels of Rev-
erbaproteinareexpectedtobetightlyregulatedwith
the correct timing. Here, we demonstrate that
Rev-erb a has an internal ribosomal entry site (IRES)
inits50 untranslatedregion.Furthermore,wedemon-
strate that heterogeneous nuclear ribonucleoprotein
Q and polypyrimidine tract-binding protein (PTB)
modulate the IRES-mediated translation of Rev-erb
a. We suggest that the rhythmic binding affinity of
hnRNP Q to the Rev-erb a IRES and the change in
PTB cytosolic levels lead to maintenance of the os-
cillation profile of the Rev-erb a protein.
INTRODUCTION
Almost all living organisms have daily physiological and
behavioral rhythms due to the rotation of the earth over a
nearly 24-h period. Even though the existence of the day
and night cycle is the main factor governing the circadian
rhythm, living creatures from cyanobacteria to humans
have a circadian oscillation control system (1,2). This en-
dogenous system is composed of an autoregulatory tran-
scription–translation feedback loop (TTFL) composed of
several clock genes (3–5). The Bmal1 and Clock
heterodimer is an active transcription complex that
binds to promoter E box elements (CACGTG) upstream
of three Period (Per) genes, two Cryptochrome (Cry) genes,
Rev-erb a, Ror a and many other clock-controlled genes
(6). After Per and Cry proteins are translated, they form a
heterodimer in the cytosol and translocate to the nucleus.
This complex binds to a BMAL1/CLOCK dimer and
directly inhibits its transcriptional activity (7,8). The
suprachiasmatic nucleus (SCN) of the anterior hypothal-
amus is in charge of master clock that synchronizes the
biological rhythms of peripheral tissues so that they
function in a deﬁned manner (9).
Among the core clock genes, Rev-erb a, also known as
Nr1d1, was identiﬁed as a regulator of lipid metabolism. It
transcriptionally represses the apoA1 and apoCb genes,
which reduce free cholesterol accumulation and constitute
the high-density lipoprotein and very low-density lipopro-
tein, respectively (10). In conjunction with these reports,
Rev-erb a
 /  mice have dyslipidemic characteristics (11).
In addition, increasing evidence has shown that Rev-erb a
plays an important role in maintenance of circadian
timing in brain and liver tissue (12,13). Because Rev-erb
a is a well-known transcriptional repressor in the positive
limb of circadian transcription, the amplitude, period
length and phase of the mRNA oscillation pattern of
several clock genes such as Bmal1, Clock and Cry1 are
largely altered in Rev-erb a
 /  mice (14,15).
Until now, the generation of mRNA and protein oscil-
lation proﬁles has been mainly explained by transcription-
al regulation by TTFL. Because proteins are the primary
effectors within cells, many scientiﬁc researches in the ﬁeld
of circadian rhythm have focused on protein–protein
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post-translational modiﬁcations (16,17). However,
mRNA quantity and quality controls should be set forth
beforehand to encode proteins properly (18,19). Among
them, regulation of translation initiation is the most im-
portant step with clock genes in particular, in order to
accurately regulate protein oscillation. Here, we suggest
that internal ribosomal entry site (IRES)-mediated trans-
lation may be a mechanism that controls the mouse
Rev-erb a (mRev-erb a) protein oscillation pattern in
NIH3T3 mouse embryo ﬁbroblast cells, which are a
good model for studying the molecular mechanism of
the mammalian circadian clock system (20,21). Even
though the IRES was ﬁrst discovered in viral genes (22),
many studies have shown that mammalian cells utilize an
IRES-mediated translation mechanism for rapid adapta-
tion to certain environments such as chemotoxic stress
(23), mitosis (24) and apoptosis (25). For IRES-
mediated translation, proteins known as IRES trans-
acting factors (ITAFs) must recognize IRES elements
in a structure or sequence-dependent manner. In this
context, we suggest that polypyrimidine tract-binding
protein (PTB), also called heterogeneous nuclear
ribonucleoprotein (hnRNP) I, and hnRNP Q are ITAFs
for the IRES-mediated translation of mRev-erb a, and
that they are necessary for maintenance of the circadian
proﬁle of mRev-erb a protein by enhancing its translation,
which is dependent on the circadian phase.
MATERIALS AND METHODS
Plasmids
To generate pRF Rev1–489, the mouse Rev-erb a (acces-
sion no. AY336125) 50-UTR was ampliﬁed with the
forward primer 50-AAGTCGACAGAGTGAAATATTA
CTGCT-30 and the reverse primer: 50-AACCCGGGGTC
TTCACCAGCTGAAAGC-30 using Pfu polymerase
(Solgent) and was conﬁrmed by sequencing. The PCR
product was digested with SalI and SmaI and inserted
into the intercistronic region of a pRF dicistronic vector
(26). To generate the inverse construct, the mRev-erb a
50-UTR was ampliﬁed with the forward primer 50-AACCC
GGGAGAGTGAAATATTACTGCT-30 and the reverse
primer 50-AAGTCGACGTCTTCACCAGCTGAAAG
C-30, digested with SmaI and SalI, and cloned into the
intercistronic region of the pRF vector. To generate
serial deletion constructs, mRev-erb a 50-UTR fragments
were ampliﬁed with forward primers 50-AAGTCGACGC
TTCTCTTCCTTTGGGAC-30 for pRF100–489, 50-AAG
TCGACTCCGGTGCACTGCAGAGAC-30 for
pRF180–489, 50-AAGTCGACCACTCTCTGCTCTTCC
CAT-30 for pRF 256–489, and the reverse primer 50-AA
CCCGGGGTCTTCACCAGCTGAAAGC-30 for all
deletion constructs. To construct the pRF reporter
lacking a promoter, the CMV promoter was removed
from pRF Rev1–489 by digestion with BglII/NheI, and
then was self-ligated. To create a hairpin-harboring con-
struct, a palindrome was inserted at the NheI site
upstream of pRF Rev1–489.
For in vitro binding followed by UV crosslinking,
full-length and deletion fragments of the mRev-erb a
50-UTR were ampliﬁed as described earlier. The PCR
products were digested with EcoRI and XbaI, and then
inserted into the pSK0 vector (27), yielding pSK0 Rev1–
489, pSK0 Rev100–489, pSK0 Rev180–489 and pSK0
Rev256–489. To generate the dicistronic mRNA reporter
for mRNA transfection, full-length and deletion frag-
ments of the mRev-erb a 50-UTR were ampliﬁed and
ligated into the intercistronic region of the pCY2-RF
vector (26), yielding pCY2-RF Rev1–489 and pCY2-RF
Rev256–489.
Cell culture and dexamethasone shock
NIH3T3 cells were maintained in DMEM (Welgene) sup-
plemented with 10% fetal bovine serum (Hyclone) and
1% penicillin–streptomycin (Welgene) in a humidiﬁed at-
mosphere containing 5% CO2 at 37 C. The dexametha-
sone shock was performed as described previously (19). In
brief,  1.5 10
5 cells were seeded in each well of a 12-well
plate. When the cells reached conﬂuence, the medium was
exchanged with medium containing 100nM dexametha-
sone. After 2h, this medium was replaced with complete
medium. Cells were harvested at the indicated times for
further experiments.
In vitro RNA synthesis and luciferase assay
For mRNA transfection, pCY2-RF Rev1–489 and
pCY2-RF Rev256–489 were linearized by digesting with
EcoRI. This plasmid contains a 20-nt long poly (A)
sequence upstream of the EcoRI site. Reporter mRNA
was in vitro transcribed with SP6 RNA polymerase
(Roche) in the presence of a cap analog. Fireﬂy and
Renilla luciferase activities were determined using the
Dual-Luciferase Reporter Assay System (Promega) ac-
cording to the manufacturer’s instructions. IRES activity
was determined as the ratio of Fireﬂy to Renilla activity.
Transient transfection
For plasmid transfection, NIH3T3 cells were seeded in
24-well plates at a density of 1 10
5 cells per well 12h
before transfection. Transfection was carried out using
Metafectene (Biontex) according to the manufacturer’s in-
structions. After incubation for 48h, cells were harvested
for further experiments. For mRNA transfection,
NIH3T3 cells were seeded in 24-well plates at a density
of 1 10
5 cells per well 12h prior to synchronization. Two
micrograms of capped reporter mRNA were transfected
into NIH3T3 cells at the indicated time points using
lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s instructions. After incubation for 6h, cells were
harvested for further experiments.
Quantitative real-time RT–PCR
Quantitative real-time RT–PCR was performed as
described previously (19). In brief, total RNA was
isolated using TRI Reagent (Molecular Research
Center). RNA was reverse transcribed using the
ImProm-II
TM Reverse Transcription System (Promega)
Nucleic Acids Research, 2010,Vol.38, No. 20 7069according to the manufacturer’s instructions. For detec-
tion and quantiﬁcation, the MyiQ
TM real-time PCR de-
tection system (Bio-Rad) was used. The sequences of the
forward and reverse primers were as follows: endogenous
mRev-erb a,5 0-CTGGAGGGCTGCAGTATAGC-30
and 50-GTCCAGGGTCGTCATGTCTT-30; ribosomal
protein L32 (mRPL32), 50-AACCCAGAGGCATTGAC
AAC-30 and 50-CACCTCCAGCTCCTTGACAT-30.
In vitro binding assay and immunoprecipitation
In vitro binding assay was performed as described earlier
(26). In brief, XbaI-linearized pSK0-50-UTR constructs
were transcribed using T7 RNA polymerase (Promega)
in the presence of [a-
32P] UTP. Twenty micrograms of
nuclear extracts or 40mg of cytosolic extracts were
incubated with labeled RNAs at 30 C. After 30min of
incubation, the mixtures were UV-irradiated on ice for
15min with a CL-1000 UV-crosslinker (UVP). The
samples were detected with autoradiography after SDS–
PAGE. To conﬁrm the identity of the UV cross-linked
protein, 3mg of a polyclonal antibody against hnRNP Q
(anti-SYNCRIP-N antibody; provided by A. Mizutani,
University of Tokyo, Japan) or polyclonal anti-PTB, or
pre-immune serum were added to RNase-digested reaction
mixtures. After 16h, Protein G agarose beads (Amersham
bioscience) were added. After a further incubation for 3h,
precipitates were detected with autoradiography after
SDS–PAGE.
Protein preparation and immunoblot analysis
For immunoblotting, cells were disrupted with complete
protein solubilizing buffer containing 1% SDS and 2M
urea in PBS, followed by sonication. Fractionation of
NIH3T3 cells into cytosolic and nuclear extracts was
performed as described (28). Immunoblot analyses were
performed with polyclonal anti-PTB, monoclonal
anti-14-3-3x (Santa Cruz), polyclonal antibody against
hnRNP Q (Sigma-Aldrich), polyclonal anti-mRev-erb a
(Cell Signaling), polyclonal phosphor-S6 ribosomal
protein (Ser 235/236) antibody (Cell Signaling), polyclonal
anti-phospho-eIF4E-BP (Cell Signaling) and polyclonal
anti-histone H2B (Upstate). HRP-conjugated mouse,
rabbit (KPL) or rat (Santa Cruz) secondary antibodies
were detected with SUPEX ECL reagent (Neuronex)
and a LAS-4000 system (FUJI FILM), according to the
manufacturer’s instructions.
RNA interference
The sequences of synthesized siRNAs were as follows.
siCon: 50-UUCUCCGAACGUGUCACGUTT-30
(Samchully Pharm.), siPTB: 50-ACACCUGUGCCUAG
CAAUATT-30 (Samchully Pharm.), sihnRNP Q: 50-AG
ACAGUGAUCUCUCUCAUTT-30 (Dharmacon
Research). For siRNA transfection into NIH3T3 cell
lines, a microporator (Digital-Bio) was used, according
to the manufacturer’s instructions.
RESULTS
Inhibition of cap-dependent translation does not alter the
kinetics of mRev-erb a protein expression
mTOR is a serine/threonine protein kinase that regulates
several cellular physiological events such as cell growth,
cell proliferation, cell survival and protein synthesis(29).
p70-S6 Kinase 1 (S6K1) and the eukaryotic initiation
factor 4E (eIF4E) binding proteins (4E-BPs) are
well-characterized targets of mTOR. Active S6K1 can
stimulate the protein synthesis by phosphorylating S6
ribosomal proteins (30). 4E-BP is another important regu-
lator of cellular translation levels. When 4E-BP is
hypophosphoryated, it impairs recruitment of the 40S
ribosomal subunit to the cap structure of mRNAs by
binding to eIF4E. However, when 4E-BP is
hyperphosphoryated, it is released from eIF4E and trans-
lation efﬁciency is increased. Rapamycin inhibits the
function of mTOR, leading to inhibition of the
cap-dependent translation by interfering both phosphor-
ylation of S6 ribosomal proteins and 4E-BPs (29,31).
Indeed, rapamycin changed the global translation level
in NIH3T3 ﬁbroblasts (Supplementary Figure S1).
To explore the regulation of translational initiation of
mRev-erb a, we suppressed protein synthesis in NIH3T3
mouse ﬁbroblasts by treating the cells with rapamycin or
cycloheximide. Compared to vehicle control, the general
translation elongation inhibitor cycloheximide caused a
rapid reduction of mRev-erb a protein 3h after treatment.
Interestingly, another translation inhibitor rapamycin did
not alter the mRev-erb a protein level, even at 9h after
treatment (Figure 1). We conﬁrmed the activity of
rapamycin by measuring the phosphorylation status
of S6 ribosomal proteins. This result could be explained
by three possibilities. First, mRev-erb a protein could be
translated in a cap-independent manner. Second, certain
proteins that protect the mRev-erb a protein from degrad-
ation could be synthesized in a cap-independent mecha
nism. Third, some factors that promote the degradation of
mRev-erb a protein could have disappeared when the
mammalian target of rapamycin pathway was inhibited
by rapamycin.
mRev-erb a mRNA possesses IRES sequences
in its 50-UTR
To identify the existence of an IRES in the mRev-erb a
transcript, we utilized a dicistronic pRF vector system
(26,32). The 50 untranslated region (UTR) of the
mRev-erb a mRNA was inserted between the Renilla
luciferase (Rluc) and ﬁreﬂy luciferase (Fluc) coding se-
quences (pRF Rev1–489), because increasing evidence
has shown that the 50-UTR is mainly responsible for trans-
lational regulation. Because Rluc is translated in a
cap-dependent manner, and the translation of Fluc is
induced in a cap-independent manner by the sequences
inserted between the Rluc stop codon and the Fluc start
codon in a cap-independent manner, the ratio of Fluc to
Rluc indicates the IRES-mediated translation efﬁciency.
We also generated another pRF-based construct to
which the 50-UTR of the mRev-erb a mRNA was
7070 Nucleic Acids Research, 2010,Vol.38, No. 20inserted in the reverse orientation to conﬁrm the sequence
speciﬁcity of the IRES elements (pRF RRev) (Figure 2A).
We conducted dual luciferase assays 48h after transfection
into NIH3T3 cells. Interestingly, the 50-UTR of the
mRev-erb a mRNA enhanced the Fluc level  6-fold
compared to the negative control that was transfected
with pRF. On the other hand, the reverse-orientated
mRNA induced Fluc translation <3-fold. To determine
the cis-acting region of IRES-mediated translation, we
performed dual luciferase assays with deletion constructs.
While there was little reduction in the Fluc level when the
50 proximal 99 and 179nt within the 50-UTR of the
mRev-erb a mRNA were deleted (pRF Rev100–489 and
pRF Rev 180–489, respectively), additional deletion of
76nt (pRF Rev 256–489) failed to induce Fluc synthesis
as much as control vector (Figure 2B).
To exclude the possibility that the enhancement of Fluc
levels came from additionally created Fluc transcripts
driven by a cryptic promoter within the 50-UTR of the
mRev-erb a mRNA, we deleted the CMV promoter in
pRF Rev (pRF CMVRev in Figure 2A). As expected,
both Rluc and Fluc expression were barely detected
(Figure 2C). This result indicated that there is no
promoter activity in the 50-UTR of the mRev-erb a
mRNA. To exclude the possibility that ribosomes
released from the Rluc stop codon could re-associate
with the start codon of Fluc to maintain synthesis of the
downstream Fluc cistron, we designed a modiﬁed pRF
Rev construct that harbors a hairpin loop upstream of
Rluc (pRF HpRev in Figure 2A). Although this loop
blocked cap-dependent translation of Rluc by  30%,
Fluc activity still remained (Figure 2C). These data
showed that Fluc translation was not driven by
ribosome reinitiation. There was no alternative splicing
or unexpected mRNA decay as conﬁrmed by northern
blot (Supplementary Figure S2).
hnRNP Q and PTB modulate IRES-mediated translation
of mRev-erb a
To determine the ITAFs that modulate IRES-mediated
translation of mRev-erb a, we conducted in vitro binding
followed by UV crosslinking. Interestingly, both a 68-kDa
protein (p68) and a 57-kDa protein (p57) showed striking-
ly higher binding afﬁnities to the full-length 50-UTR of the
mRev-erb a mRNA (Rev1–489) in both cytosolic and
nuclear fractions, but not to the deletion transcript,
which displayed only mild Fluc activity (Figure 2D). As
anticipated, binding of these two proteins remained until
the 50 proximal 179nt were deleted (Figure 2E). This
strong correlation between the IRES activity of the
serial deletion reporters and the binding pattern of the
two proteins to the deletion constructs suggested that
p68 and p57 are strong candidates for ITAFs.
We previously reported that hnRNP Q enhances
IRES-mediated translation of AANAT in rat pinealocytes
(26). Moreover, several lines of evidence have
demonstrated that PTB can function as an ITAF at viral
or cellular IRES (25,33). Notably, the molecular weights
of hnRNP Q and PTB are  68 and 57kDa, respectively.
Therefore, we determined whether hnRNP Q and PTB
bound to the 50-UTR of the mRev-erb a mRNA with
UV crosslinking followed by immunoprecipitation with
antibodies against hnRNP Q and PTB.
Both the 68kDa and the 57kDa bands, which showed
dramatically reduced binding to the Rev256–489 con-
struct, were clearly detected in precipitates using
anti-hnRNP Q and anti-PTB, respectively. In contrast,
we did not observe any detectable bands in precipitates
using pre-immune serum (Figure 2F). In addition, we
tested whether both antibodies against hnRNP Q and
PTB interact with their targets speciﬁcally in UV
cross-linking followed by immunoprecipitation experi-
ment that we performed (Figure 2G). PTB was detected
in immunoprecipitate with PTB antibody, but absent in
other precipitates. hnRNP Q was also only found in
immunoprecipitate with hnRNP Q antibody. 14-3-3 was
not detectable in any precipitates. Therefore, we con-
ﬁrmed that the 68kDa and the 57kDa bands were
hnRNP Q and PTB, respectively.
Knockdown of hnRNP Q and PTB induces rapamycin
sensitivity in the mRev-erb a protein
To conﬁrm whether hnRNP Q and PTB modulate the
IRES activity of mRev-erb a, overexpression and
knockdown experiments were performed. Overexpression
of hnRNP Q and PTB augmented the IRES activity of
mRev-erb a by about 2- and 3-fold, respectively. The
negative control pRF mock vector and the deletion con-
struct pRF Rev256–489 were barely affected by the
overexpression of hnRNP Q and PTB (Figure 3A
DMSO Rapamycin CHX
mRev-erb
0      3      6      9 0      3      6      9 0      3      6 9 (hours after treatment) 
Phospho-rpS6
14-3-3
α
Figure 1. mRev-erb a protein is not degraded by rapamycin treatment. The levels of mRev-erb a protein were analyzed by western blotting.
mRev-erb a protein was rapidly decreased following cycloheximide treatment, but was insensitive to rapamycin. Phospho-rpS6 is a phosphorylated
S6 ribosomal protein. 14-3-3 was used as a loading control. DMSO, dimethyl sulfoxide; CHX, cycloheximide.
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7072 Nucleic Acids Research, 2010,Vol.38, No. 20and B). As expected, reduction of hnRNP Q and PTB
reduced the IRES activity of mRev-erb a to about 60
and 20%, respectively, compared to the control treated
with scrambled siRNA. The negative control was not
inﬂuenced by the above knockdown experiments.
This result suggested that hnRNP Q and PTB may
modulate the IRES activity of mRev-erb a (Figure 3C
and D).
In light of the results that insensitivity of mRev-erb a to
rapamycin is derived from IRES-mediated translation of
mRev-erb a by ITAFs, reduction of hnRNP Q and PTB
should diminish the level of mRev-erb a when
cap-dependent translation is blocked by rapamycin. To
test this hypothesis, we treated vehicle or rapamycin to
NIH3T3 mouse ﬁbroblasts in which hnRNP Q and/or
PTB level is lessened. When hnRNP Q or PTB was
downregulated independently, the level of the mRev-erb
a protein still remained high 9h after rapamycin treatment
(Supplementary Figure S3A and B). However, when both
hnRNP Q and PTB were downregulated, mRev-erb a
protein was clearly diminished 9h after treatment with
rapamycin (Figure 3E). We therefore suggest that
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control. Downregulation of hnRNP Q (C) and PTB (D) was conﬁrmed by western blotting (right panels). (A–D) All results are representative of at
least three independent experiments. The error bars represent the mean±SEM of duplicate measurements (left panels). (E) Kinetics of mRev-erb a
protein was analyzed by western blotting when both hnRNP Q and PTB were downregulated, in which mRev-erb a protein became sensitive to
rapamycin treatment. In contrast, mRev-erb a protein was still insensitive to rapamycin treatment in control siRNA transfected cells. The relative
band intensities of mRev-erb a proteins are shown below the bands. The intensities at 0h were arbitrarily set as 1. siCon, control siRNA-transfected
extract. Phospho-rpS6 was used as a marker of rapamycin treatment. Knockdown efﬁciencies of hnRNP Q and PTB were identiﬁed by western
blotting. 14-3-3 was used as a loading control. siCon, control siRNA-transfected extract.
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of mRev-erb a in a combinatorial mode.
Knockdown of hnRNP Q and PTB disrupts the rhythmic
oscillation of the mRev-erb a protein
Because mRev-erb a has its own molecular circadian
rhythm, we hypothesized that alteration in IRES-
mediated translation would lead to an abnormal oscilla-
tion pattern of the mRev-erb a protein. To analyze the
rhythmic proﬁles of the mRev-erb a mRNA and
protein, we harvested NIH3T3 ﬁbroblasts every 6h after
phase-synchronization with dexamethasone treatment.
Using real-time quantitative RT–PCR, we identiﬁed the
ﬁrst peak between 18 and 24h after synchronization in
the endogenous mRev-erb a mRNA proﬁle. The second
peak was observed at nearly 42h after dexamethasone
treatment (Figure 4A). This result indicates that
mRev-erb a mRNA oscillates with about a 24-h period
in NIH3T3 cells. We further conﬁrmed that the
mRev-erb a protein also oscillates with approximately a
24-h period, even though the peak time was delayed by
 6h compared to the mRNA oscillation pattern
(Figure 4B).
To test whether a deﬁciency in hnRNP Q and PTB
affects the mRNA and protein proﬁles of mRev-erb a,
we transfected siRNAs against hnRNP Q and PTB into
NIH3T3 cells. Interestingly, the mRev-erb a protein
did not oscillate robustly in hnRNP Q and PTB
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mRev-erb a protein oscillation was not altered in
control siRNA-transfected cells (Figure 4D). On the
other hand, mRNA oscillation showed a similar pattern
between hnRNP Q and PTB siRNA-cotransfected
NIH3T3 cells and control siRNA transfected NIH3T3
cells (Figure 4C). This result suggests that
IRES-mediated translation by hnRNP Q and PTB is
necessary to generate the oscillation of the mRev-erb a
protein without requiring a signiﬁcant difference in the
mRNA oscillation pattern.
IRES-mediated translation occurs in a phase-dependent
manner
It should be noted that the oscillation may be generated
when synthesis and degradation are dynamically
regulated. In other words, during the rising phase, the
synthesis rate would exceed the decay rate, and this
would occur reversely during the declining phase. In this
context, we hypothesized that IRES-mediated translation
may be regulated in a phase-dependent manner in which
IRES-activity would be the highest when the mRev-erb a
protein is approaching its peak level. Two mRNA report-
ers were generated from in vitro transcription of the pRF
Rev 1–489 and pRF Rev 256–489 constructs (Rev1–489
and Rev256–489, respectively). These two mRNA report-
ers were transiently transfected into NIH3T3 ﬁbroblasts at
19, 23, 29 and 35h after phase-synchronization with dexa-
methasone. Six hours after transfection, we analyzed the
IRES activity of each mRNA reporter in the different
phases. Interestingly, the IRES activity of the Rev 1–489
mRNA reporter was greatly increased during the 29- to
35-h time period, compared to the other time points
(Figure 5A). Remarkably, this time period correlated
well to the peak time of mRev-erb a protein oscillation.
At other time points, the IRES activity of the Rev 256–489
mRNA reporter was not signiﬁcantly changed.
Because phase-dependent IRES activity may be
modulated by phase-dependent ITAF association with
IRES, we analyzed the binding dynamics between the
50-UTR of the mRev-erb a mRNA and hnRNP Q and
PTB using UV crosslinking. As expected, hnRNP Q
bound to the 50-UTR of the mRev-erb a mRNA more
strongly during both the 24- to 30-h time period and the
48- to 54-h time period after synchronization, in agree-
ment with the mRev-erb a protein proﬁle (Figure 5B).
For PTB, we previously reported that PTB differentially
translocates to the cytoplasm, depending on the phase
(18). We conﬁrmed that the cytosolic PTB level was the
highest 30h after synchronization, even though the total
level of PTB was constant (Figure 5C). Collectively, our
data suggest that IRES-mediated translation of mRev-erb
a is regulated in a phase-dependent manner through the
rhythmic binding afﬁnity of hnRNP Q and cytosolic PTB
proteins to their 50-UTR s.
DISCUSSION
Our results provide several evidences suggesting that the
mRev-erb a mRNA is translated to protein in a
cap-independent manner as well as cap-dependent
manner and that both hnRNP Q and PTB modulate the
IRES activity of mRev-erb a. The importance of hnRNP
Q and PTB in maintaining the rhythmicity of mRev-erb a
protein oscillation was veriﬁed by knockdown experi-
ments in phase-synchronized NIH3T3 mouse ﬁbroblasts.
Furthermore, we suggest that the phase-dependent
IRES-mediated translation by hnRNP Q and PTB is a
regulatory mechanism for the rhythmic control of the
mRev-erb a protein.
Nevertheless, we could not totally exclude the possibil-
ity that hnRNP Q and PTB also regulate mRev-erb a
protein oscillation by affecting other factors that
modulate the mRev-erb a protein level. Because it has
been reported that both hnRNP Q and PTB can mediate
cap-independent translations of several genes, there still
remains the possibility that certain proteins which could
be synthesized in a cap-independent mechanism by
hnRNP Q or PTB can affect the mRev-erb a protein
level in some extent. In our results, downregulation of
hnRNP Q and PTB does not affect the mRNA stability
of mRev-erb a (Supplementary Figure S4B and C).
However, as we previously reported that PTB could
control the mRNA stability of mPer2 and mPer2
proteins can inhibit the transcription of mRev-erb a
mRNA, PTB and hnRNP Q can regulate mRev-erb a
level indirectly. It is also possible that hnRNP Q and
PTB post-translationally inﬂuence mRev-erb a protein
activity, perhaps by affecting protein degradation
kinetics. Indeed, we could not observe the full synergistic
reduction of Fluc level when both of hnRNP Q and PTB
were perturbated in dicistronic pRF vector transient trans-
fection (Supplementary Figure S4A). Therefore, it would
be important to explore whether other kinds of modula-
tion of mRev-erb a by hnRNP Q and PTB also exist.
We observed an  6-fold increase in IRES activity of
mRev-erb a in our DNA transient transfection experiment
compared to the negative control, but we observed less
than a 2-fold increase in Fluc translation in the mRNA
transfection test (unpublished data). This may be ex-
plained by two reasons. First, it takes time for ITAFs to
recruit several different types of translation initiation
machineries to fully induce IRES-mediated translation.
Indeed, we analyzed luciferase activity only 6h after trans-
fection of mRNA, compared to 36h after DNA transfec-
tion. The more likely possibility is that nuclear experience
is important for sufﬁcient translation via an IRES. Even
though IRES-mediated translation occurs in the cyto-
plasm, increasing evidence has shown that gene expression
steps are interconnected from transcription to translation
(34). Therefore, a number of hnRNPs and RNA-binding
factors that are involved in transcription, splicing, mRNA
export, mRNA decay and translation associate with their
target mRNAs in a combinatorial and/or serial manner.
Meanwhile, they recruit other factors that are needed for
the next stage. In this context, some proteins, including
hnRNP Q and PTB, which bound to the IRES element of
mRev-erb a in the nucleus may enhance the IRES activity
by facilitating recruitment of other unidentiﬁed ITAFs or
translation initiation machineries. Accordingly, the in vitro
transcribed mRNA reporter did not exhibit full IRES
Nucleic Acids Research, 2010,Vol.38, No. 20 7075activity because it remained only in the cytoplasm. In
addition, because the level of hnRNP Q and PTB is
usually much higher in the nucleus than in the cytoplasm,
in vitro transcribed mRNA reporters may interact with a
limited amount of hnRNP Q and PTB.
Because mRev-erb a is a main component of the
autoregulatory transcription–translation feedback loop
in the mammalian circadian clock system, perturbation
of mRev-erb a protein oscillation may affect the transcrip-
tion efﬁciency, mRNA level and oscillation pattern of
mRNAs and proteins of other clock genes. Indeed, we
observed alteration of the mRNA levels of several clock
genes following knockdown of hnRNP Q and PTB (un-
published data). Although the variation in the oscillatory
pattern of other clock molecules remains to be
determined, our results suggest that post-transcriptional
regulation by hnRNP Q and PTB is necessary to
maintain the feedback loop.
It will be necessary to test whether IRES-mediated
translation of mRev-erb a occurs in vivo. In particular,
because the SCN functions as the master clock for
regulating the peripheral clock, the molecular study of
clock genes in the SCN is a prerequisite for understanding
animal physiology. If the IRES-mediated translation of
Rev-erb a is also present in the SCN and is regulated by
both hnRNP Q and PTB, dysfunction of hnRNP Q and
PTB may lead to perturbations in animal circadian behav-
iors such as sleep regulation or physiological homeostasis.
In addition, because Rev-erb a can function during adi-
pocyte differentiation and the immune response, the role
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7076 Nucleic Acids Research, 2010,Vol.38, No. 20of post-transcriptional regulation including IRES-
mediated translation in various physiological conditions
should be investigated in the future.
Studies of cellular IRES-mediated translation have
continued since the viral IRES was discovered.
Increasing evidence suggests that IRES-mediated transla-
tion is involved in various physiological activities such as
mitosis, apoptosis and stress conditions. More rapid trans-
lation via the IRES is likely beneﬁcial for cells to quickly
adapt to certain situations without changing the efﬁciency
of transcription, thus saving time and energy. In the case
of circadian rhythms, it is possible that many
clock-controlled genes utilize IRES-mediated translation
so that they are properly and robustly induced at the
right time. Our results shed light on the molecular regula-
tory mechanism of the mammalian circadian oscillation
system.
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